163 related articles for article (PubMed ID: 21076469)
1. ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion.
Yagi R; Tanaka M; Sasaki K; Kamata R; Nakanishi Y; Kanai Y; Sakai R
Oncogene; 2011 Mar; 30(12):1413-21. PubMed ID: 21076469
[TBL] [Abstract][Full Text] [Related]
2. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma.
Tanaka M; Kamata R; Takigahira M; Yanagihara K; Sakai R
Am J Pathol; 2007 Jul; 171(1):68-78. PubMed ID: 17591954
[TBL] [Abstract][Full Text] [Related]
4. CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.
Uekita T; Tanaka M; Takigahira M; Miyazawa Y; Nakanishi Y; Kanai Y; Yanagihara K; Sakai R
Am J Pathol; 2008 Jun; 172(6):1729-39. PubMed ID: 18467693
[TBL] [Abstract][Full Text] [Related]
5. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.
Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ
Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis and progression of scirrhous carcinoma].
Naito Y; Kino I
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2364-70. PubMed ID: 7944478
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical distribution of heat shock protein 47 (HSP47) in scirrhous carcinoma of the stomach.
Hirai K; Kikuchi S; Kurita A; Ohashi S; Adachi E; Matsuoka Y; Nagata K; Watanabe M
Anticancer Res; 2006; 26(1A):71-8. PubMed ID: 16475681
[TBL] [Abstract][Full Text] [Related]
10. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
[TBL] [Abstract][Full Text] [Related]
12. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
13. A novel RNA-binding protein, Ossa/C9orf10, regulates activity of Src kinases to protect cells from oxidative stress-induced apoptosis.
Tanaka M; Sasaki K; Kamata R; Hoshino Y; Yanagihara K; Sakai R
Mol Cell Biol; 2009 Jan; 29(2):402-13. PubMed ID: 19015244
[TBL] [Abstract][Full Text] [Related]
14. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.
Yanagihara K; Takigahira M; Tanaka H; Komatsu T; Fukumoto H; Koizumi F; Nishio K; Ochiya T; Ino Y; Hirohashi S
Cancer Sci; 2005 Jun; 96(6):323-32. PubMed ID: 15958054
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Uraoka N; Oshima T; Yanagihara K; Oue N; Yasui W
Oncol Rep; 2014 Jul; 32(1):403-10. PubMed ID: 24807047
[TBL] [Abstract][Full Text] [Related]
16. Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells.
Kuramitsu Y; Baron B; Yoshino S; Zhang X; Tanaka T; Yashiro M; Hirakawa K; Oka M; Nakamura K
Anticancer Res; 2010 Nov; 30(11):4459-65. PubMed ID: 21115893
[TBL] [Abstract][Full Text] [Related]
17. Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells.
Yamaguchi H; Yoshida N; Takanashi M; Ito Y; Fukami K; Yanagihara K; Yashiro M; Sakai R
PLoS One; 2014; 9(1):e85485. PubMed ID: 24427313
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.
Matsuzaki T; Yashiro M; Kaizaki R; Yasuda K; Doi Y; Sawada T; Ohira M; Hirakawa K
Cancer Sci; 2009 Dec; 100(12):2402-10. PubMed ID: 19764996
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
Murakami N; Koufuji K; Shirouzu K
Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of collagen synthesis in an in-vitro model of scirrhous carcinoma of the stomach.
Kurita A; Kikuchi S; Kakita A
Hepatogastroenterology; 2002; 49(47):1235-8. PubMed ID: 12239912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
